av/beximco-pharmaceuticals-ltd--big.svg

COM:BEXIMCOPHARMA

Beximco Pharma

  • Stock

Last Close

34.00

08/11 15:09

Market Cap

1.73M

Beta: -

Volume Today

76.80K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
revenue
10.49B
-
11.21B
6.83%
12.97B
15.69%
15.51B
19.62%
17.72B
14.24%
22.82B
28.79%
25.61B
12.25%
29.49B
15.16%
34.67B
17.55%
39.27B
13.26%
cost of revenue
5.65B
-
6.10B
7.98%
6.97B
14.13%
8.32B
19.51%
9.43B
13.30%
12.20B
29.32%
13.71B
12.43%
15.57B
13.54%
18.85B
21.10%
21.95B
16.43%
gross profit
4.84B
-
5.10B
5.48%
6.00B
17.56%
7.18B
19.74%
8.29B
15.33%
10.62B
28.17%
11.90B
12.04%
13.92B
17.01%
15.81B
13.58%
17.31B
9.48%
selling and marketing expenses
2.14B
-
2.29B
6.93%
2.70B
18.08%
3.21B
19.02%
3.64B
13.28%
4.80B
31.86%
5.50B
14.48%
6.38B
16.00%
7.75B
21.54%
8.92B
15.06%
general and administrative expenses
375.57M
-
398.76M
6.18%
448.36M
12.44%
522.40M
16.51%
618.68M
18.43%
752.94M
21.70%
792.95M
5.31%
896.65M
13.08%
1.16B
29.75%
1.18B
1.44%
selling general and administrative expenses
2.51B
-
2.69B
6.82%
3.15B
17.24%
3.74B
18.66%
4.26B
14.00%
5.55B
30.39%
6.29B
13.24%
7.27B
15.63%
8.91B
22.55%
10.10B
13.29%
research and development expenses
27.87M
-
31.05M
11.39%
36.20M
16.60%
43.23M
19.43%
49.08M
13.53%
49.46M
0.78%
180.95M
265.82%
234.68M
29.70%
281.22M
19.83%
364.42M
29.59%
other expenses
510.59M
-
521.17M
2.07%
311.68M
40.20%
144.85M
53.52%
43.76M
69.79%
151.47M
246.16%
54.86M
63.78%
88.07M
60.53%
78.01M
11.42%
452.66M
480.28%
cost and expenses
8.27B
-
8.89B
7.53%
10.23B
15.03%
12.21B
19.29%
13.86B
13.55%
17.95B
29.53%
20.24B
12.74%
23.17B
14.46%
28.13B
21.42%
32.36B
15.07%
operating expenses
2.62B
-
2.79B
6.58%
3.27B
17.00%
3.88B
18.84%
4.43B
14.09%
5.76B
29.97%
6.53B
13.38%
7.60B
16.40%
9.27B
22.07%
10.41B
12.29%
interest expense
636.59M
-
724.31M
13.78%
708.97M
2.12%
557.00M
21.43%
540.28M
3.00%
1.03B
90.60%
1.01B
1.55%
858.69M
15.30%
1.00B
16.67%
1.29B
28.33%
ebitda
2.73B
-
2.83B
3.80%
3.05B
7.49%
3.45B
13.21%
3.90B
13.14%
4.98B
27.53%
5.67B
13.90%
7.24B
27.69%
7.69B
6.25%
7.35B
4.35%
operating income
2.32B
-
2.42B
4.04%
2.85B
17.91%
3.45B
20.94%
4.03B
16.76%
5.07B
25.83%
5.61B
10.72%
6.65B
18.56%
6.90B
3.77%
7.22B
4.56%
depreciation and amortization
68.91M
-
90.19M
30.87%
84.95M
5.80%
98.11M
15.48%
845.91M
762.23%
-90.35M
110.68%
57.75M
163.92%
585.53M
913.90%
787.49M
34.49%
138.23M
82.45%
total other income expenses net
-126.00M
-
-203.14M
61.23%
-397.29M
95.57%
-412.15M
3.74%
-509.18M
23.54%
-1.12B
119.98%
-956.05M
14.65%
-273.16M
71.43%
-214.34M
21.53%
-1.15B
435.35%
income before tax
2.09B
-
2.11B
0.76%
2.34B
10.79%
2.89B
23.72%
3.36B
16.25%
3.95B
17.40%
4.65B
17.93%
6.38B
37.05%
6.69B
4.85%
6.07B
9.24%
income tax expense
688.83M
-
581.26M
15.62%
382.85M
34.14%
664.79M
73.64%
828.68M
24.65%
905.66M
9.29%
1.11B
22.45%
1.21B
9.27%
1.69B
39.32%
1.54B
8.53%
net income
1.40B
-
1.53B
8.79%
1.95B
27.87%
2.23B
13.94%
2.54B
13.92%
3.03B
19.59%
3.51B
15.87%
5.13B
45.89%
5.12B
0.09%
4.61B
9.94%
weighted average shs out
446.11M
-
446.11M
0%
424.87M
4.76%
446.11M
5.00%
446.11M
0%
446.11M
0%
445.92M
0.04%
446.11M
0.04%
446.11M
0%
446.11M
0%
weighted average shs out dil
446.11M
-
446.11M
0%
446.11M
0%
446.11M
0.00%
446.11M
0%
446.11M
0%
445.92M
0.04%
446.11M
0.04%
446.11M
0%
446.23M
0.03%
eps
3.15
-
3.43
8.89%
4.38
27.70%
4.99
13.93%
5.69
14.03%
6.80
19.51%
7.88
15.88%
11.49
45.81%
11.48
0.09%
10.34
9.93%
epsdiluted
3.15
-
3.43
8.89%
4.38
27.70%
4.99
13.93%
5.69
14.03%
6.80
19.51%
7.88
15.88%
11.49
45.81%
11.48
0.09%
10.34
9.93%

All numbers in (except ratios and percentages)